SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-21-000064
Filing Date
2021-05-03
Accepted
2021-05-03 16:11:08
Documents
16
Period of Report
2021-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-20210503.htm   iXBRL 8-K 33646
2 EX-99.1 q12021earningsreleaseex99_1.htm EX-99.1 145492
8 image11a.jpg GRAPHIC 36525
  Complete submission text file 0000886163-21-000064.txt   392267

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20210503.xsd EX-101.SCH 2430
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20210503_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20210503_def.xml EX-101.DEF 1655
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20210503_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20210503_pre.xml EX-101.PRE 12654
9 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20210503_htm.xml XML 10786
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 21883661
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences